US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SPDR S&P Telecom ETF

170.41

+9.595.96%

Post-market: 170.460.0479+0.03%16:10 EST

Volume:9.78K

Turnover:1.64M

Market Cap:255.62M

PE:- -

High:170.46

Open:165.06

Low:165.06

Close:160.82

52wk High:171.10

52wk Low:84.68

Shares:1.50M

Float Shares:1.50M

Volume Ratio:0.42

T/O Rate:0.65%

Dividend:1.61

Dividend Rate:0.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency

XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure

XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XTL"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XTL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XTL\",,,,,undefined,":{"symbol":"XTL","market":"US","secType":"STK","nameCN":"SPDR S&P Telecom ETF","latestPrice":170.4121,"timestamp":1770411600000,"preClose":160.8249,"halted":0,"volume":9784,"hourTrading":{"tag":"盘后","latestPrice":170.46,"preClose":170.4121,"latestTime":"16:10 EST","volume":12,"amount":2044.9452,"timestamp":1770412205031,"change":0.0479,"changeRate":0.000281,"amplitude":0},"delay":0,"changeRate":0.059612659482455733,"floatShares":1500000,"shares":1500000,"eps":0,"marketStatus":"Market Closed","change":9.5872,"latestTime":"02-06 16:00:00 EST","open":165.06,"high":170.46,"low":165.06,"amount":1640138.0907,"amplitude":0.033577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":160.8249,"sharesOutstanding":1500000,"nav":161.477495,"aum":242216242.88,"dividendRate":0.009455,"bidAskSpread":0.003052,"postHourTrading":{"tag":"盘后","latestPrice":170.46,"preClose":170.4121,"latestTime":"16:10 EST","volume":12,"amount":2044.9452,"timestamp":1770412205031,"change":0.0479,"changeRate":0.000281,"amplitude":0},"volumeRatio":0.41928074433288953,"impliedVol":0.2369,"impliedVolPercentile":0.8645},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XTL\",,,,,undefined,":{"symbol":"XTL","floatShares":1500000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.41928074433288953,"shares":1500000,"dividePrice":1.6112,"high":170.46,"amplitude":0.033577,"preClose":160.8249,"low":165.06,"week52Low":84.68,"pbRate":"--","week52High":171.1,"institutionHeld":0,"latestPrice":170.4121,"eps":0,"divideRate":0.009455,"volume":9784,"delay":0,"ttmEps":0,"open":165.06,"prevYearClose":153.22,"prevWeekClose":165.607,"prevMonthClose":165.607,"prevQuarterClose":153.22,"fiveDayClose":165.607,"twentyDayClose":156.35,"sixtyDayClose":146.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XTL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XTL","amount":0.104143,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR标普电信ETF基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XTL","amount":1.025961,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR标普电信ETF基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XTL","amount":0.208087,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR标普电信ETF基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XTL","amount":0.271426,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR标普电信ETF基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XTL","amount":0.130665,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR标普电信ETF基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XTL\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.177479,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.1828039,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.1806129,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.2275269,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.227197,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XTL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XTL\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606371755","title":"XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2606371755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606371755?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:17","pubTimestamp":1769609841,"startTime":"0","endTime":"0","summary":"The latest announcement is out from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ). On January 28, 2026, XTL Biopharmaceuticals Ltd. announced it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","BK4588","BK4215","NQmain","XTL","XTLB","BK4585","BK4139"],"gpt_icon":0},{"id":"2605612286","title":"XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605612286?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:11","pubTimestamp":1769206267,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) just unveiled an update. On January 23, 2026, XTL Biopharmaceuticals reported that its wholly owne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTL","XTLB"],"gpt_icon":0},{"id":"2605286646","title":"XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286646","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605286646?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:10","pubTimestamp":1769206256,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has provided an announcement. On January 23, 2026, XTL Biopharmaceuticals disclosed that it receiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4139","EQR","BK4585","NQmain","BK4588","XTL","XTLB"],"gpt_icon":0},{"id":"2605285567","title":"XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2605285567","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605285567?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:10","pubTimestamp":1769202600,"startTime":"0","endTime":"0","summary":"RAMAT GAN, ISRAEL, Jan.  23, 2026  (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/23/3225065/0/en/XTL-Announces-Receipt-of-Nasdaq-Notification-Regarding-Minimum-Stockholders-Equity-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","BK4215","BK4139","EQR","BK4585","91348","SLE","BK4588","XTL","XTLB"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XTL\",params:#limit:6,delay:false,,,undefined,":[]}}